Clinical Trials Logo

Filter by:
NCT ID: NCT02331355 Withdrawn - Clinical trials for Amputation; Traumatic, Hand

Hand Transplantation: Functional and Quality of Life Outcomes

Start date: April 2016
Phase:
Study type: Observational

There is an urgent need to develop hand transplant programs in this country. To this end, the University of Michigan Hospital and Health Systems is developing such an interdisciplinary program. The Transplant Center would like to track the patient experience from pre-operative care through surgery and post-operative care. Detailed information will be collected from the patient medical records, including: Pre-operative screening, demographics, medications; Surgical information ; Post-operative inpatient and out-patient care; laboratory and other test results; physical assessments, psychological assessments and quality of life assessments.

NCT ID: NCT02331212 Withdrawn - Clinical trials for Stage IV Breast Cancer

Role of Hyaluronic Acid in Causing Cancer Stem Cell Growth in the Bones of Patients With Breast Cancer

Start date: March 2015
Phase:
Study type: Observational

This research trial studies the role of a substance called hyaluronic acid in causing the growth of cancer stem cells in the bones of patients with breast cancer. Cancer stem cells are a type of cancer cells that may cause the cancer to spread to other parts of the body. Studying samples of blood and bone marrow from patients and animal models in the laboratory may help doctors learn more about whether hyaluronic acid affects the growth of cancer in the bones.

NCT ID: NCT02329756 Withdrawn - Placenta Accreta Clinical Trials

Tranexamic Acid in Adherent Placenta (TAP)

Start date: December 2018
Phase: Phase 3
Study type: Interventional

The objective of this study is to investigate the effect of tranexamic acid (TXA) administration on the outcome of cesarean-hysterectomy in women with suspected Morbidly Adherent Placenta (MAP; placenta accreta, increta, percreta).

NCT ID: NCT02328911 Withdrawn - Clinical trials for Diabetic Peripheral Neuropathy

Laser Therapy for Diabetic Peripheral Neuropathic Pain

Start date: January 2015
Phase: Phase 2
Study type: Interventional

The proposed study is a randomized, double-blinded clinical trial to evaluate the efficacy of a course of laser therapy on peripheral neuropathic pain in persons with diabetes. The hypothesis is that laser therapy will produce significant improvement on measures of self-reported pain among adults with diabetes.

NCT ID: NCT02328300 Withdrawn - Brain Metastases Clinical Trials

FLT PET/MR for Evaluation of Pseudoprogression in Patients With Brain Lesions

Start date: May 7, 2014
Phase:
Study type: Observational

This is a single arm, single center study of 15 patients with brain lesions being treated at UNC Hospitals. Subjects will undergo one (1) FLT-PET-MRI scan before their scheduled surgical biopsy of their brain lesion(s).

NCT ID: NCT02324933 Withdrawn - Pain, Postoperative Clinical Trials

Post-Operative Pain Control in Opioid Tolerant Patients: Fentanyl Challenge Protocol Versus Standard of Care

Start date: August 2014
Phase: Phase 4
Study type: Interventional

This study will evaluate the value of dosing pain medications based upon a patient's pre-operative tolerance to pain medications. Study participants will be assigned to one of two groups, a treatment group and a control group. The treatment group will be given pain medications after surgery based upon their measured response to pain medications prior to surgery. The control group will be given pain medications based upon the normal dosing routine as is currently practiced. Both groups will be closely monitored for side effects and have their pain scores recorded for the first 48 hours following surgery.

NCT ID: NCT02322996 Withdrawn - Post op Pain Clinical Trials

Phenotyping Acute Pain for Discovery Research and Directed Therapeutics

Start date: February 21, 2018
Phase: N/A
Study type: Observational

The goal of the current study is to combine existing and new tools for quantifying patient self-report to characterize changes in acute pain. The ability to quantitatively measure self-report provides behavioral pain phenotypes that can serve as the basis for clustering patients into sub-groups based on their self-report of their symptoms, eliminating observer based perceptions of patients' pain.

NCT ID: NCT02322541 Withdrawn - Clinical trials for Focus is Understanding Absorption of Garlic Metabolites

Dietary Absorption of Garlic Metabolites Following Garlic Consumption

Start date: September 2016
Phase: N/A
Study type: Interventional

The study will consist of a single 5-day dietary treatment period. Subjects will consume an Allium-free diet for 3 days. Alliums are vegetables such as garlic, onions, chives, shallots, and leeks. On day 4, subjects will consume a breakfast consisting of garlic and will then provide blood and urine samples for 10 hours, and on the following morning.

NCT ID: NCT02321306 Withdrawn - Clinical trials for Primary Biliary Cirrhosis

An Open-label Study to Evaluate the Long-term Safety and Tolerability of LUM001 in Patients With Primary Biliary Cirrhosis

CASCADE
Start date: May 2015
Phase: Phase 2
Study type: Interventional

Open-label, multicenter study in adults with Primary Biliary Cirrhosis (PBC) designed to evaluate the long-term safety and tolerability of daily dosing with LUM001.

NCT ID: NCT02320201 Withdrawn - Overactive Bladder Clinical Trials

Foot Neuromodulation for Overactive Bladder in Children

Start date: September 2014
Phase: N/A
Study type: Interventional

To determine the effects of electrical stimulation of the nerves in the foot on overactive bladder conditions in children.